Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
IndyGeneUS AI
AddedFeb 16, 2024
UpdatedJun 18, 2026
IndyGeneUS AI

IndyGeneUS AI

Pre-Seed

IndyGeneUS AI: A genomics firm creating a secure, blockchain-encrypted digital bio-bank.

HQ
Washington, D.C., DC, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

IndyGeneUS AI, founded by a team of experts in genomics and blockchain technology, is a black-owned and service-disabled veteran-owned small business. The company's core mission is to revolutionize the field of genomics by creating a secure, blockchain-encrypted digital bio-bank. This innovative bio-bank aims to enhance the accessibility and security of genomic data, particularly focusing on underserved populations. IndyGeneUS AI offers advanced genomic solutions that cater to researchers, healthcare providers, and individuals seeking personalized medicine.

Notable figures affiliated with IndyGeneUS AI include its founders, who bring extensive experience in both genomics and blockchain technology. The company has attracted significant interest from investors focused on health tech and data security. Key achievements include the successful development and implementation of their blockchain-encrypted bio-bank, which has garnered attention for its potential to democratize access to genomic data. IndyGeneUS AI's impact is evident in its commitment to inclusivity and innovation in the genomics field, setting new standards for data security and accessibility.

IndyGeneUS AI - Similar Companies

Data Driven Bioscience logo

Data Driven Bioscience

Bioinfoexperts logo

Bioinfoexperts

bioinfox.com

Unite Genomics logo

Unite Genomics

GenomeNext logo

GenomeNext

Streamline Genomics logo

Streamline Genomics

InSyBio logo

InSyBio

insybio.gr

Polaris Genomics logo

Polaris Genomics

LifeNome logo

LifeNome

Omix.ai logo

Omix.ai

Nucleus logo

Nucleus

Myfloradna logo

Myfloradna

myfloradna.com

Genometry logo

Genometry

Nest Genomics logo

Nest Genomics

nestgenomics.com

Genome Insight logo

Genome Insight

Verge Genomics logo

Verge Genomics

vergegenomics.com

IndyGeneUS AI - Quick Facts

Who are IndyGeneUS AI's competitors?

Companies similar to IndyGeneUS AI include Data Driven Bioscience, Bioinfoexperts, Unite Genomics and GenomeNext.

When was IndyGeneUS AI founded?

IndyGeneUS AI was founded in 2021.

Where is IndyGeneUS AI's headquarters located?

IndyGeneUS AI's headquarters is located in Washington, D.C., DC, US.

When was IndyGeneUS AI's last funding round?

IndyGeneUS AI's most recent funding round was for $50k (USD) in December 2022.

How much has IndyGeneUS AI raised to-date?

As of Dec 19, 2022, IndyGeneUS AI has raised a total of $1.8M (USD).

How many employees does IndyGeneUS AI have?

IndyGeneUS AI has 6 employees as of Feb 4, 2024.

IndyGeneUS AI - Classification

Technology
  • Blockchain
Geographic Exposure
  • Americas
Model
  • Platform
Revenue
  • Recurring
Customer
  • Consumers
  • Enterprise
Main Product
  • Genomic Data
Tags
  • Biotech
  • Data
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software